ONLINE DATABASE SEARCH - OI-LS-294-MEMO
1. 43254 OI-LS-294; PUBMED-HIV-4/20/2004
Association of serum interleukin-8 with virologic response to antiviral therapy in patients with chronic hepatitis C
Mihm, U, Herrmann, E, Sarrazin, U, Von Wagner, M, Kronenberger, B, Zeuzem, S, and Sarrazin, C
J Hepatol 2004. 40(5): 845-52
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15094234&dopt=abstract
2. 43255 OI-LS-294; PUBMED-HIV-4/20/2004
Quantitative analysis of phagolysosome fusion in intact cells: inhibition by mycobacterial lipoarabinomannan and rescue by an 1{alpha},25-dihydroxyvitamin D3-phosphoinositide 3-kinase pathway
Hmama, Z, SendiDe K, Talal, A, Garcia, R, Dobos, K, and Reiner, NE
J Cell Sci 2004. 117(Pt 10): 2131-2140
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15090599&dopt=abstract
3. 43256 OI-LS-294; PUBMED-HIV-4/20/2004
Pernicious anemia associated with interferon-alpha therapy and chronic hepatitis C infection
Andres, E, Loukili, NH, Ben Abdelghani, M, and Noel, E
J Clin Gastroenterol 2004. 38(4): 382
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15087703&dopt=abstract
4. 43257 OI-LS-294; EMBASE-OI-4/21/2004
The use of microarray analysis to determine the gene expression profiles of Mycobacterium tuberculosis in response to anti-bacterial compounds*1, *2
Waddell, Simon J, Stabler, Richard A, Laing, Ken, Kremer, Laurent, Reynolds, Robert C, and Besra, Gurdyal S
Tuberculosis 2004. In Press, Corrected Proof
HYPERLINK: http://www.sciencedirect.com/science/article/B6WXK-4C6KSB5-4/2/b1bde265d366332120b07a73e70667dc
5. 43258 OI-LS-294; EMBASE-OI-4/21/2004
Differential effects of the combination of caspofungin and terbinafine against Candida albicans, Candida dubliniensis and Candida kefyr
Gil-Lamaignere, C and Muller, F-MC
International Journal of Antimicrobial Agents 2004. In Press, Corrected Proof
HYPERLINK: http://www.sciencedirect.com/science/article/B6T7H-4C606FR-H/2/60d7d784db2e989a40aa94b1036be1ac
6. 43259 OI-LS-294; EMBASE-OI-4/21/2004
Complete development of Cryptosporidium parvum in rabbit chondrocytes (VELI cells)
Lacharme, Lizeth, Villar, Vega, Rojo-Vazquez, Francisco A, and Suarez, Susana
Microbes and Infection 2004. In Press, Uncorrected Proof
HYPERLINK: http://www.sciencedirect.com/science/article/B6VPN-4C5G6B6-2/2/d50cbd01428d4d682c10b1c65b1341f8
7. 43260 OI-LS-294; PUBMED-HIV-4/20/2004
Transfer factors as immunotherapy and supplement of chemotherapy in experimental pulmonary tuberculosis
Fabre, RA, Perez, TM, Aguilar, LD, Rangel, MJ, Estrada-Garcia, I, Hernandez-Pando, R, and Estrada, Parra S
Clin Exp Immunol 2004. 136(2): 215-23
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15086383&dopt=abstract
8. 43261 OI-LS-294; PUBMED-HIV-4/20/2004
Effect of antimetabolite immunosuppressants on Flaviviridae, including hepatitis C virus
Stangl, JR, Carroll, KL, Illichmann, M, and Striker, R
Transplantation 2004. 77(4): 562-7
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15084936&dopt=abstract
9. 43262 OI-LS-294; EMBASE-OI-4/21/2004
Ring-substituted quinolines as potential anti-tuberculosis agents*1
Vangapandu, Suryanarayana, Jain, Meenakshi, Jain, Rahul, Kaur, Sukhraj, and Pal Singh, Prati
Bioorganic & Medicinal Chemistry 2004. In Press, Corrected Proof
HYPERLINK: http://www.sciencedirect.com/science/article/B6TF8-4C4DWVY-4/2/8aded61e3403642bedab87b63dadafe3
10. 43263 OI-LS-294; PUBMED-HIV-4/20/2004
Structure-Activity Relationship of Purine Ribonucleosides for Inhibition of Hepatitis C Virus RNA-Dependent RNA Polymerase
Eldrup, AB, Allerson, CR, Bennett, CF, Bera, S, Bhat, B, Bhat, N, Bosserman, MR, Brooks, J, Burlein, C, Carroll, SS, Cook, PD, Getty, KL, MacCoss, M, McMasters, DR, Olsen, DB, Prakash, TP, Prhavc, M, Song, Q, Tomassini, JE, and Xia, J
J Med Chem 2004. 47(9): 2283-2295
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15084127&dopt=abstract
11. 43264 OI-LS-294; EMBASE-OI-4/21/2004
Natural antimycobacterial metabolites: current status
Okunade, Adewole L, Elvin-Lewis, Memory PF, and Lewis, Walter H
Phytochemistry 2004. In Press, Corrected Proof
HYPERLINK: http://www.sciencedirect.com/science/article/B6TH7-4C47HH4-8/2/7fd5d9760b8bbf2da9684372c1bc65d2
12. 43265 OI-LS-294; PUBMED-HIV-4/20/2004
Cofactor mimics as selective inhibitors of NAD-dependent inosine monophosphate dehydrogenase (IMPDH)--the major therapeutic target
Pankiewicz, KW, Patterson, SE, Black, PL, Jayaram, HN, Risal, D, Goldstein, BM, Stuyver, LJ, and Schinazi, RF
Curr Med Chem 2004. 11(7): 887-900
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15083807&dopt=abstract
13. 43266 OI-LS-294; EMBASE-OI-4/21/2004
Synthesis and biological evaluation of oxindoles and benzimidazolinones derivatives
Messaoudi, Samir, Sancelme, Martine, Polard-Housset, Valerie, Aboab, Bettina, Moreau, Pascale, and Prudhomme, Michelle
European Journal of Medicinal Chemistry 2004. In Press, Corrected Proof
HYPERLINK: http://www.sciencedirect.com/science/article/B6VKY-4C47S60-2/2/8ce00051163a90bb71852e3b388965b4
14. 43267 OI-LS-294; EMBASE-OI-4/21/2004
Heterocyclic compounds such as pyrrole, pyridines, pyrrolidine, piperidine, indole, imidazol and pyrazines
Higashio, Yasuhiko and Shoji, Takayuki
Applied Catalysis A: General 2004. 260(2): 251-259
HYPERLINK: http://www.sciencedirect.com/science/article/B6TF5-4BY3XH8-1/2/948294668582a682e4716675cd5384f9
15. 43268 OI-LS-294; PUBMED-HIV-4/20/2004
The vitro efficacy of beta-lactam and beta-lactamase inhibitors against multidrug resistant clinical strains of Mycobacterium tuberculosis
Dincer, I, Ergin, A, and Kocagoz, T
Int J Antimicrob Agents 2004. 23(4): 408-411
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15081094&dopt=abstract
16. 43269 OI-LS-294; EMBASE-OI-4/21/2004
Antiviral drugs in current clinical use*1
De Clercq, Erik
Journal of Clinical Virology 2004. In Press, Corrected Proof
HYPERLINK: http://www.sciencedirect.com/science/article/B6VJV-4C40YN3-1/2/841b34d1a7c7a0e0f960fa18b5e0a969
17. 43270 OI-LS-294; PUBMED-HIV-4/20/2004
Capped dipeptide phenethylamide inhibitors of the HCV NS3 protease
Nizi, E, Koch, U, Ontoria, JM, Marchetti, A, Narjes, F, Malancona, S, Matassa, VG, and Gardelli, C
Bioorg Med Chem Lett 2004. 14(9): 2151-2154
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15080998&dopt=abstract
18. 43271 OI-LS-294; EMBASE-OI-4/21/2004
PknH, a transmembrane Hank's type serine/threonine kinase from Mycobacterium tuberculosis is differentially expressed under stress conditions
Sharma, Kirti, Chandra, Harish, Gupta, Pradeep K, Pathak, Monika, Narayan, Azeet, Meena, Laxman S, D'Souza, Rochelle CJ, Chopra, Puneet, Ramachandran, S, and Singh, Yogendra
FEMS Microbiology Letters 2004. 233(1): 107-113
HYPERLINK: http://www.sciencedirect.com/science/article/B6T2W-4BSW4D7-2/2/00d7ce10de3e104ce3616a1604cbe478
19. 43272 OI-LS-294; PUBMED-HIV-4/20/2004
Antifungal Susceptibilities of Cryptococcus neoformans
Archibald, LK
Emerg Infect Dis 2004. 10(1): 143-5
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15078612&dopt=abstract
20. 43273 OI-LS-294; PUBMED-HIV-4/20/2004
Tetracycline in combination with sodium dioctylsulfosuccinate show increased antimicrobial activity in resistant microorganisms
Simonetti, G, Simonetti, N, and Villa, A
J Chemother 2004. 16(1): 38-44
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15077997&dopt=abstract
21. 43274 OI-LS-294; EMBASE-OI-4/21/2004
Cloning and expression of the trehalose-phosphate phosphatase of Mycobacterium tuberculosis: comparison to the enzyme from Mycobacterium smegmatis
Edavana, Vineetha Koroth, Pastuszak, Irena, Carroll, JD, Thampi, Prajitha, Abraham, Edathera C, and Elbein, Alan D
Archives of Biochemistry and Biophysics 2004. In Press, Corrected Proof
HYPERLINK: http://www.sciencedirect.com/science/article/B6WB5-4BYJWG0-3/2/4462eec4224174085114084dc6f07715
22. 43275 OI-LS-294; PUBMED-HIV-4/20/2004
Synthesis and evaluation of ATP-binding site directed potential inhibitors of nucleoside triphosphatases/helicases and polymerases of hepatitis C and other selected Flaviviridae viruses
Bretner, M, Schalinski, S, Haag, A, Lang, M, Schmitz, H, Baier, A, Behrens, SE, Kulikowski, T, and Borowski, P
Antivir Chem Chemother 2004. 15(1): 35-42
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15074713&dopt=abstract
23. 43276 OI-LS-294; EMBASE-OI-4/21/2004
Multicenter evaluation of reverse line blot assay for detection of drug resistance in Mycobacterium tuberculosis clinical isolates
Mokrousov, Igor, Bhanu, NVijaya, Suffys, Philip N, Kadival, Gururaj V, Yap, Sook-Fan, Cho, Sang-Nae, Jordaan, Annemarie M, Narvskaya, Olga, Singh, Urvashi B, and Gomes, Harrison M
Journal of Microbiological Methods 2004. In Press, Corrected Proof
HYPERLINK: http://www.sciencedirect.com/science/article/B6T30-4BY3X0W-1/2/2255c3ed94c1cd52e5befc5c9d19194e
24. 43277 OI-LS-294; PUBMED-HIV-4/20/2004
Hepatitis C Virus (HCV) Diversity in HIV-HCV-Coinfected Subjects Initiating Highly Active Antiretroviral Therapy
Blackard, JT, Yang, Y, Bordoni, P, Sherman, KE, and Chung, RT
J Infect Dis 2004. 189(8): 1472-81
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15073685&dopt=abstract
25. 43278 OI-LS-294; PUBMED-HIV-4/20/2004
The MspA porin promotes growth and increases antibiotic susceptibility of both Mycobacterium bovis BCG and Mycobacterium tuberculosis
Mailaender, C, Reiling, N, Engelhardt, H, Bossmann, S, Ehlers, S, and Niederweis, M
Microbiology 2004. 150(Pt 4): 853-864
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15073295&dopt=abstract
26. 43279 OI-LS-294; EMBASE-OI-4/21/2004
Selection of an Escherichia coli host that expresses mutant forms of Mycobacterium tuberculosis 2-trans enoyl-ACP(CoA) reductase and 3-ketoacyl-ACP(CoA) reductase enzymes
Poletto, Simone S, da Fonseca, Isabel O, de Carvalho, Luiz PS, Basso, Luiz A, and Santos, Diogenes S
Protein Expression and Purification 2004. 34(1): 118-125
HYPERLINK: http://www.sciencedirect.com/science/article/B6WPJ-4B8BMMK-1/2/80dceb9ba8359614bec494341b5db530
27. 43280 OI-LS-294; EMBASE-OI-4/21/2004
Free tuberculosis drugs from Novartis
Ahmad, Khabir
The Lancet Infectious Diseases 2004. 4(2): 66
HYPERLINK: http://www.sciencedirect.com/science/article/B6W8X-4BJVHRS-7/2/f209d141d04e1e93323b420e1b1e6811
28. 43281 OI-LS-294; PUBMED-HIV-4/20/2004
Treatment of chronic hepatitis C in HIV/HCV-coinfection with interferon alpha-2b+ full-course vs. 16-week delayed ribavirin
Brau, N, Rodriguez-Torres, M, Prokupek, D, Bonacini, M, Giffen, CA, Smith, JJ, Frost, KR, and Kostman, JR
Hepatology 2004. 39(4): 989-98
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15057903&dopt=abstract
29. 43282 OI-LS-294; PUBMED-HIV-4/20/2004
Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatment
Shiffman, ML, Di Bisceglie, AM, Lindsay, KL, Morishima, C, Wright, EC, Everson, GT, Lok, AS, Morgan, TR, Bonkovsky, HL, Lee, WM, Dienstag, JL, Ghany, MG, Goodman, ZD, and Everhart, JE
Gastroenterology 2004. 126(4): 1015-1023; discussion 947
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15057741&dopt=abstract
30. 43283 OI-LS-294; EMBASE-OI-4/21/2004
TB drug discovery: addressing issues of persistence and resistance
Smith, Clare V, Sharma, Vivek, and Sacchettini, James C
Tuberculosis 2004. 84(1-2): 45-55
HYPERLINK: http://www.sciencedirect.com/science/article/B6WXK-4B5B3Y1-6/2/7c77b2d0cdfa35dc1ca064765e6d2f05
31. 43284 OI-LS-294; EMBASE-OI-4/21/2004
Inhibition of Clotrimazole-resistant Candida albicans by plants used in Iranian folkloric medicine
Shahidi Bonjar, GH
Fitoterapia 2004. 75(1): 74-76
HYPERLINK: http://www.sciencedirect.com/science/article/B6VSC-49WPSSX-5/2/d9211e67cba457638d9173c806247e62
32. 43285 OI-LS-294; PUBMED-HIV-4/20/2004
Caspofungin resistance in Candida albicans: correlating clinical outcome with laboratory susceptibility testing of three isogenic isolates serially obtained from a patient with progressive Candida esophagitis
Hernandez, S, Lopez-Ribot, JL, Najvar, LK, McCarthy, DI, Bocanegra, R, and Graybill, JR
Antimicrob Agents Chemother 2004. 48(4): 1382-3
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15047549&dopt=abstract
33. 43286 OI-LS-294; PUBMED-HIV-4/20/2004
Potent synergistic in vitro interaction between nonantimicrobial membrane-active compounds and itraconazole against clinical isolates of Aspergillus fumigatus resistant to itraconazole
Afeltra, J, VitaLe RG, Mouton, JW, and Verweij, PE
Antimicrob Agents Chemother 2004. 48(4): 1335-43
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15047538&dopt=abstract
34. 43287 OI-LS-294; EMBASE-OI-4/21/2004
Interfering with hepatitis C virus RNA replication
Randall, Glenn and Rice, Charles M
Virus Research 2004. 102(1): 19-25
HYPERLINK: http://www.sciencedirect.com/science/article/B6T32-4BVP8BS-1/2/8147c77ae24eb54ce22b9c2daed7c0b5
35. 43288 OI-LS-294; PUBMED-HIV-4/20/2004
Disposition of caspofungin, a novel antifungal agent, in mice, rats, rabbits, and monkeys
Sandhu, P, Xu, X, Bondiskey, PJ, Balani, SK, Morris, ML, Tang, YS, Miller, AR, and Pearson, PG
Antimicrob Agents Chemother 2004. 48(4): 1272-80
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15047529&dopt=abstract
36. 43289 OI-LS-294; EMBASE-OI-4/21/2004
Anti-HCV activities of selective polyunsaturated fatty acids
Leu, Guang-Zhou, Lin, Tiao-Yin, and Hsu, John TA
Biochemical and Biophysical Research Communications 2004. In Press, Corrected Proof
HYPERLINK: http://www.sciencedirect.com/science/article/B6WBK-4C5PTHC-F/2/ac81823e406d7053bc1190bca9d19107
37. 43290 OI-LS-294; EMBASE-OI-4/21/2004
Structure-activity relationships for the selectivity of hepatitis C virus NS3 protease inhibitors
Poliakov, Anton, Johansson, Anja, Akerblom, Eva, Oscarsson, Karin, Samuelsson, Bertil, Hallberg, Anders, and Danielson, UHelena
Biochimica et Biophysica Acta (BBA) - General Subjects 2004. 1672(1): 51-59
HYPERLINK: http://www.sciencedirect.com/science/article/B6T1W-4BW9NM9-1/2/280855c3c0525972fa44aa7e6f94c2bd
38. 43291 OI-LS-294; EMBASE-OI-4/21/2004
63 In-vitro and in-vivo evaluation of HCV polymerase inhibitors as potential drug candidates for treatment of chronic hepatitis C infection
Dagan, S, Ilan, E, Aviel, S, Nussbaum, O, Arazi, E, Ben-Moshe, O, Slama, D, Tzionas, I, Shoshany, Y, and Lee, SW
Journal of Hepatology 2004. 40(Supplement 1): 23
HYPERLINK: http://www.sciencedirect.com/science/article/B6W7C-4C5WW3G-28/2/3bae4eb66319cce4e2d3c2c0f8c62136
39. 43292 OI-LS-294; EMBASE-OI-4/21/2004
492 A phase II, placebo-controlled study of merimepodib (XV-497), in combination with pegylated interferon-alfa, and ribavirin in patients with chronic hepatitis C non-responsive to previous therapy with interferon-alfa and ribavirin
Marcellin, P, Horsmans, Y, Nevens, F, Grange, JD, Bronowicki, JP, Vetter, D, Kauffman, R, Knox, S, McNair, L, Moseley, S, and Alam, J
Journal of Hepatology 2004. 40(Supplement 1): 145
HYPERLINK: http://www.sciencedirect.com/science/article/B6W7C-4C5WW3G-KK/2/c80c36029583978229fa14ff8d13f6c6
40. 43293 OI-LS-294; WOS-OI-4/11/2004
Comparative cytotoxicity of N-substituted N '-(4-imidazole-ethyl)thiourea in precision-cut rat liver slices
Onderwater, RCA, Commandeur, JNM, and Vermeulen, NPE
TOXICOLOGY 2004. 197(2): 81-91
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000220322700001
41. 43294 OI-LS-294; WOS-OI-4/11/2004
Anti-Candida and mode of action of two newly synthesized polymers: a modified poly (methylmethacrylate-co-vinylbenzoylchloride) and a modified linear poly (chloroethylvinylether-co-vinylbenzoylchloride) with special reference to Candida albicans and Candida tropicalis
Mahmoud, YAG and Aly, MM
MYCOPATHOLOGIA 2004. 157(2): 145-153
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000220341600001
42. 43295 OI-LS-294; WOS-OI-4/11/2004
Antimicrobial activities of selected Cyathus species
Liu, YJ and Zhang, KQ
MYCOPATHOLOGIA 2004. 157(2): 185-189
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000220341600007
43. 43296 OI-LS-294; WOS-OI-4/11/2004
Inhibitors of hepatitis C virus NS3 center dot 4A protease 2. Warhead SAR and optimization
Perni, RB, Pitlik, J, Britt, SD, Court, JJ, Courtney, LF, Deininger, DD, Farmer, LJ, Gates, CA, Harbeson, SL, Levin, RB, Lin, C, Lin, K, Moon, YC, Luong, YP, O'Malley, ET, Rao, BG, Thomson, JA, Tung, RD, Van, Drie JH, and Wei, YY
BIOORG MED CHEM LETT 2004. 14(6): 1441-1446
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000220334000016
44. 43297 OI-LS-294; WOS-OI-4/11/2004
Structure determination of tetrahydroquinazoline antifolates in complex with human and Pneumocystis carinii dihydrofolate reductase: correlations between enzyme selectivity and stereochemistry
Cody, V, Luft, JR, Pangborn, W, Gangjee, A, and Queener, SF
ACTA CRYSTALLOGR D 2004. 60: 646-655
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000220368300004
45. 43298 OI-LS-294; WOS-OI-4/18/2004
Survival of Mycobacterium avium in a model distribution system
Norton, CD, LeChevallier, MW, and Falkinham, JO
WATER RES 2004. 38(6): 1457-1466
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000220462200010
46. 43299 OI-LS-294; WOS-OI-4/18/2004
Inhibition of hepatitis C virus IRES-mediated translation by small RNAs analogous to stem-loop structures of the 5 '-untranslated region
Ray, PS and Das, S
NUCLEIC ACIDS RES 2004. 32(5): 1678-1687
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000220487200013
47. 43300 OI-LS-294; WOS-OI-4/18/2004
Interplay between mycobacteria and host signalling pathways
Koul, A, Herget, T, Klebl, B, and Ullrich, A
NAT REV MICROBIOL 2004. 2(3): 189-202
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000220431800011
48. 43301 OI-LS-294; WOS-OI-4/18/2004
Dinitroanilines bind alpha-tubulin to disrupt microtubules
Morrissette, NS, Mitra, A, Sept, D, and Sibley, LD
MOL BIOL CELL 2004. 15(4): 1960-1968
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000220450800042
49. 43302 OI-LS-294; WOS-OI-4/18/2004
Treatment of multidrug-resistant tuberculosis
Colebunders, R, Apers, L, and Shamputa, IC
LANCET 2004. 363(9416): 1240
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000220748100040
50. 43303 OI-LS-294; WOS-OI-4/18/2004
Evaluation of the fully automated BACTEC MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide, streptomycin, isoniazid, rifampin, and ethambutol and comparison with the radiometric BACTEC 460TB method
Scarparo, C, Ricordi, P, Ruggiero, G, and Piccoli, P
J CLIN MICROBIOL 2004. 42(3): 1109-1114
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000220376900026
51. 43304 OI-LS-294; WOS-OI-4/18/2004
Antibiotics GE23077, novel inhibitors of bacterial RNA polymerase I. Taxonomy, isolation and characterization
Ciciliato, I, Corti, E, Sarubbia, E, Stefanelli, S, Gastaldo, L, Montanini, N, Kurz, M, Losi, D, Marinelli, F, and Selva, E
J ANTIBIOT 2004. 57(3): 210-217
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000220465900006
52. 43305 OI-LS-294; WOS-OI-4/18/2004
Synthesis and evaluation of analogues of S-adenosyl-L-methionine, as inhibitors of the E-coli cyclopropane fatty acid synthase
Guerard, C, Breard, M, Courtois, F, Drujon, T, and Ploux, O
BIOORG MED CHEM LETT 2004. 14(7): 1661-1664
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000220411200011
53. 43306 OI-LS-294; WOS-OI-4/18/2004
Mannich reaction: an approach for the synthesis of water soluble mulundocandin analogues
Lal, B, Gund, VG, Bhise, NB, and Gangopadhyay, AK
BIOORGAN MED CHEM 2004. 12(7): 1751-1768
HYPERLINK:
http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000220481200016